NFBC Eye Study
Research unit: PEDEGO
Group leaders
Ville Saarela and Johanna Liinamaa
What do we do
The NFBC eye study offers a unique opportunity to conduct the first randomised glaucoma screening trial in the world in an unselected population. The eye examinations will be performed with modern imaging tools, in order to investigate the benefits, possible disadvantages and cost-effectiveness of eye screening in glaucoma diagnostics. It also highlights relationship between birth weight and growth patterns during early life to the development of eye diseases and gives an unique opportunity to study the retinal vascular parameters and their relationship with pathophysiologic processes. It is likely that retinal vascular changes might be markers of the early preclinical stages of metabolic disorders and might predict the onset of clinical disease.
Our team
Senior scientists
- Hagman Juha, MD, PhD
- Hägg Pasi, MD, PhD
- Kuoppala Jaana, MD, PhD
- Luodonpää Marja, MD, PhD
- Nevalainen Jukka, MD, PhD
- Taanila Anja, professor
- Tuulonen Anja, professor
PhD students
- Geneid Mohamed, MD
- Karvonen Elina, MD
- Kettunen Joonas, Med. Cand.
- Kurikka Jukka, MD
- Pitkänen Hanna, MD
- Stoor Katri, MD
Support staff
- Autio Anna, optometrist, st
Where are we headed
Modern imaging tools are used in order to explore the long-term morbidity, intermediate disease markers and symptom variation throughout the life-course. The study highlights the relationship between risk factors and their value in predicting future glaucoma and other eye abnormalities. The purpose is to identify high risk groups and biological markers to give tools for early intervention and prevention.
Our main collaborators
Committee members
How to find us
Last updated: 9.7.2019